Posted 08 April, 2024
Contineum Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:CTNM in a 424B4 filed on 08 April, 2024.
This is an initial public offering of shares of Class A common stock of Contineum Therapeutics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Contineum Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.Market Cap
$157M
View Company Details
$157M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.